Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes
NCT ID: NCT00396851
Last Updated: 2006-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gurmar
Metformin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting plasma glucose \>126mg/dl
* HbA1c \> 7%
Exclusion Criteria
* History of drug abuse
* History of recent weight loss
25 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indian Council of Medical Research
OTHER_GOV
International Clinical Epidemiology Network (INCLEN) TRUST
NETWORK
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deepak Bhasin, MD,DM
Role: STUDY_CHAIR
Post Graduate Institute of Medical Education and Research, Chandigarh
Anil Bhansali
Role: PRINCIPAL_INVESTIGATOR
Post Graduate Institute of Medical Education and Research, Chandigarh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PGIMER
Chandigarh, , India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Samir Malhotra
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Gnesin F, Thuesen ACB, Kahler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020 Jun 5;6(6):CD012906. doi: 10.1002/14651858.CD012906.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pharma 6/700
Identifier Type: -
Identifier Source: org_study_id